Real Brands, Inc. (OTCMKTS: RLBD) files its application to the OTC Markets Group for an uplisting to the OTCQB market. Thom Kidrin, CEO, says the transaction is part of RLBD’s ‘executing strategy’ for growth in 2022. RLBD’s catalysts are its plans in the fast-growing marijuana/hemp space with proprietary brands.
‘STEP BY STEP,’ RLBD EXECUTING ON 2022 STRATEGY
“Step by step, we are executing on the strategy that we have shared with our investors and shareholders,” says Kidrin. “With our submission completed, we now await the OTC’s review and approval.”
- RLBD has prior filed Form 10
- The Company is compliant with two years of audited financials
- RLBD is a fully reporting company subject to the requirements of securities laws
- Filed submission of compliance paperwork
RLBD stock will benefit because more investors will be able to act after this uplisting. This is the ideal time to do your due diligence before the crowd starts to learn about Real Brands.
RLBD MAKES A COMMITMENT TO DEVELOPING PROPRIETARY BRANDS
Once approved, RLBD will launch its prior announced strategy for 2022 growth. This company’s primary business has been pharmaceutical-grade extraction of cannabinoid extraction of CBD isolate and distillate. It also extracts terpenes and minor cannabinoids.
$RLBD’s development of proprietary formulation, production and sales of hemp-derived consumer products as well as novel formulations of products such as topical creams, gels, cosmetics, tinctures, oils, vape cartridges and other related products containing hemp derivative distillate or isolate and other minor cannabinoids; all fit into the company’s growth strategy.
RLBD PLANS ONLINE SALES, LICENSING AND DISTRIBUTION
Kidrin added, “Our brand development strategy is to leverage our existing resources into creating online sales, licensing opportunities and a distribution network for proprietary legal hemp and, eventually, cannabis brands and other consumer brands.”
He explained that RLBD is also planning to acquire and/or develop brands that contain CBD and minor cannabinoids.
“We anticipate up listing to the OTCQB will help us in funding these endeavors as it provides us with greater credibility and exposure to a more sophisticated and discerning caliber of investor who appreciate the transparency afforded by the additional reporting requirements.”
In our last interview, Kidrin told Top News Guide, “I have five major deals waiting for us after the up list. Once that is finalized, everything else can start. I can announce them.”
This could mean exciting times are ahead for RLBD stockholders.
This is not a typical penny stock. RLBD has an affiliation with Turning Point Brands, Inc. (NYSE: TPB) and $9 billion assets under management (AUM) hedge fund Standard General.
TPB owns 23% equity interest in RLBD stock. In turn, private hedge fund Standard General owns less than 20% equity ownership of TPB.
CROSS EQUITY OWNERSHIP IN ALTERNATIVE SMOKING SPACE
All that cross-equity ownership is unique in the penny stock world. These are billion-dollar corporations owning RLBD stock.
All are in the marijuana/hemp adult consumer alternative smoking space.
The common interest between RLBD, strategic investor TPD, and hedge fund SG is the marijuana/cannabis space. All are in branded products in alternative adult consumer smoking.
Kidrin launched RLBD when he engineered a reverse merger with Canadian American Standard Hemp (OTCMKTS: CASH). He left MariMed, Inc. (OTCQX: MRMD) to launch RLBD.
Learn more at https://realbrands.com/
— Twitter https://twitter.com/RealBrandsInc
Keep RLBD stock on your Watch List as hemp-infused products and CBD are growing in importance to the investor community.
This article is part of a sponsored investor education program.